Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/11/2010CN101797279A Health care product with dealcoholic function
08/11/2010CN101797277A Method for detecting Jingan capsule
08/11/2010CN101797276A Compound vitamin nanoemulsion
08/11/2010CN101797269A Physiological balance liquid for adjusting microecology in vaginas of women
08/11/2010CN101797268A Stable compound dimeticone hydrotalcite suspension
08/11/2010CN101797267A Medical composite for preventing and curing Alzheimer's disease
08/11/2010CN101797266A Pharmaceutical composition containing quercetin and usage thereof
08/11/2010CN101797265A Application of belamcanda chinensis total isoflavone or isoflavone compounds in preparing medicaments and food for preventing and treating women's disease
08/11/2010CN101797264A Amphotericin B lipid complex for injection and preparation method thereof
08/11/2010CN101797263A Traditional Chinese medicine composite for antibiosis and antiphlogosis
08/11/2010CN101797262A Western medicine powder for treating dental ulcer of infant
08/11/2010CN101797261A Method for preparing monostalotetrahexosyl gangliside GM1 compound
08/11/2010CN101797260A Application of L-arabinopyranose in preparing medicines for treating telotism dysfunction
08/11/2010CN101797259A Compound vitamin nanoemulsion
08/11/2010CN101797258A Medicine composition containing oral glucocorticoid and oral bronchodilator
08/11/2010CN101797257A Hormone preparation for sow aphrodisiac
08/11/2010CN101797256A Application of oleanolic acid in preparation of medicaments for treating skin scar
08/11/2010CN101797255A Tablet capsule filled with dihydroergocryptine mesylate A tablet and caffeine tablet in capsule
08/11/2010CN101797254A Ointment for radical treatment of beriberi and preparation method
08/11/2010CN101797253A Bergenin and cetirizine dihydrochloride compound oral administration preparation
08/11/2010CN101797252A Application of Huperzine A in preparing medicaments
08/11/2010CN101797251A Inhibitor for acetylcoenzyme A synthetase in human pathogen clostridium difficile
08/11/2010CN101797250A Stable compound preparation
08/11/2010CN101797249A Medicinal composition containing pyridyl cyanoguanidine as well as preparation and application thereof
08/11/2010CN101797248A Method for hydrogenating vitamin E oil in presence of supercritical CO2 as dissolving agent
08/11/2010CN101797247A Application of isoflavone compound in preparation of anti-tumor drug or food
08/11/2010CN101797246A Application of radix scutellariae and flavonoid against sub-type infection of influenza virus A (H1N1)
08/11/2010CN101797245A Nanoparticulate fibrate formulations
08/11/2010CN101797244A Levodopa/benserazide orally disintegrating tablet
08/11/2010CN101797243A Composition containing levodopa and borneol, and application thereof
08/11/2010CN101797242A Application of cysteamine in preparing medicine for treating cancer
08/11/2010CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
08/11/2010CN101797238A Method for preparing medicinal preparation for releasing rifampicin on upper part of small intestine and characteristics of medicinal preparation
08/11/2010CN101797237A Betahistine mesilate orally disintegrating tablet and preparation method thereof
08/11/2010CN101797236A Rivastigmine orally disintegration tablet and preparation method thereof
08/11/2010CN101797235A Carbazochrome sodium sulfonate oral disintegrating tablets and preparation method thereof
08/11/2010CN101797233A Nanoparticulate fibrate formulations
08/11/2010CN101797231A Method for controlling quality of Ceftezole sodium used for injection
08/11/2010CN101797230A Liposome solid preparation of losartan potassium hydrochlorothiazide pharmaceutical composition
08/11/2010CN101797228A Method for preparing oryzanol microemulsion
08/11/2010CN101797227A High oxidation resistance long chain fat emulsion injection and preparation method thereof
08/11/2010CN101797226A High oxidation resistance medium/long chain fat emulsion injection and preparation method thereof
08/11/2010CN101797225A High oxidation resistance long chain fat emulsion injection and preparation method thereof
08/11/2010CN101797224A Breviscapinun nose drop and preparation method thereof
08/11/2010CN101797223A Huperzine A preparations for eyes and application thereof
08/11/2010CN101797222A Morphine sulfate sustained/controlled-release suppository and preparation method thereof
08/11/2010CN101797221A Oral drug delivery system comprising high viscosity liquid carrier materials
08/11/2010CN101797220A Oxaliplatin chitosan-stearic acid grafting micelle and application
08/11/2010CN101797219A Solid sustained- release implant for curing esophageal carcinoma and preparation method thereof
08/11/2010CN101797218A Prescription for preparing paracetamol freezable oral liquid
08/11/2010CN101485673B Roxithromycin and ambroxol hydrochloride dispersible tablets
08/11/2010CN101455660B Use of glaucocalyxin X in preparing anti-cancer medicine
08/11/2010CN101411690B 2-methoxyestradiol lipidosome freeze-dried injection and preparation method thereof
08/11/2010CN101353333B 10- deacetylate-9(R)-hydrogenization-1-deoxypaclitaxel analogue and preparation thereof
08/11/2010CN101352419B Acebrophylline sugar-free type granular formulation and preparation method thereof
08/11/2010CN101318933B Isoquinolinium compounds with antithrombotic activity, preparation method and application thereof
08/11/2010CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof
08/11/2010CN101293876B Benzoxazole ketones derivative and preparation method thereof
08/11/2010CN101270143B Triterpene saponin antineoplastic compound, preparing method and uses
08/11/2010CN101264075B Application of 2', 5, 6', 7-tetrahydroxy dihydroflavonol for treating sepsis
08/11/2010CN101259100B Etoposide preparations and preparation thereof
08/11/2010CN101250119B Dinaphthol derivatives as well as preparation method and uses thereof
08/11/2010CN101244174B Medicine for treating angiitis and preparation thereof
08/11/2010CN101244040B Dioscorea opposita saponin liposome, method for preparing its preparations and uses thereof
08/11/2010CN101229184B DNA degradation fragment compound and applications thereof
08/11/2010CN101194917B Grifola frondosa oral liquid rich in gastrodine, organic selenium and method for preparing the same
08/11/2010CN101190925B Copper complex, preparation method and application thereof
08/11/2010CN101185651B Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazin in preparing medicine
08/11/2010CN101181568B Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache
08/11/2010CN101176731B Application of asiatic acid in the aspect of resisting pulmonary fibrosis
08/11/2010CN101156834B Ammonia temperature responsive form gel and its preparation method
08/11/2010CN101108236B Hemiparalysis restoration pill
08/11/2010CN101103978B Berberine resin composition and its preparation method and medicinal composition containing the same
08/11/2010CN101098867B Substituted sulfoxide compound and its preparing method and application
08/11/2010CN101073574B Medicine for treating diabetes mellitus
08/11/2010CN101073568B Use of medicine for treating or preventing heart failure
08/11/2010CN101066267B Solid oral medicine composition containing aripiprazole microcrystal
08/11/2010CN101049345B A preparation for treating disease of oral cavity and gorge, and preparation method
08/11/2010CN101043888B Processes for the preparation of isothiazole derivatives
08/11/2010CN101039930B 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt
08/11/2010CN101037436B L-stepholidine (l-SPD) derivatives, preparation method and usage thereof
08/11/2010CN101036656B Stable cefoperazone tazobactam medicine compound preparation
08/11/2010CN101029005B Method for producing 1-acetoxy-piperonyl acetate
08/11/2010CN101011409B Collunarium containing vitamin B12
08/11/2010CN101006047B TRPV1 agonists, formulations containing them and uses thereof
08/10/2010USRE41491 for suppression of secondary hyperparathyroidism of renal osteodystrophy; treats autoimmune diseases, including multiple sclerosis, lupis, diabetes mellitus, host versus graft reaction, and rejection of organ transplants; antiinflammtory and anticarcinogenic agent
08/10/2010USRE41489 Method of providing sustained analgesia with buprenorphine
08/10/2010US7772444 Method for the production of resveratrol in a recombinant oleaginous microorganism
08/10/2010US7772439 compounds comprising a phosphoramidite moiety and a protecting group bonded to a linker chain, and reporter group bonded to the protecting group, used for the functionalization, derivatization and modification that can be introduced into nucleotides
08/10/2010US7772434 salt formation to form N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; crystal forms
08/10/2010US7772433 SARMS and method of use thereof
08/10/2010US7772430 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
08/10/2010US7772427 Uses for amino acid anticonvulsants
08/10/2010US7772425 Vitamin D receptor modulators
08/10/2010US7772412 flowing sorbitol in a reactor, counter flowing H2 in the reactor in the absence of H2O, in presence of solid acid catalyst or mineral acid catalyst and a cocatalyst selected from Pt, Pd, Ni, Fe Ir etc. on a support ( SnO2, SiO2 etc.) to produce isosorbide; H2 removes any H2O formed during exposure
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772406 Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
08/10/2010US7772403 oxidation and chlorination of 5S)-5-[(benzylthio)methyl]-, 5S)-5-[(tert-butylthio)methyl]- or (5S)-5-[(tert-butylsulfinyl)methyl]-, 5-methylimidazolidine-2,4-dione, in a one pot process to yield [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride
08/10/2010US7772394 Zaleplon synthesis
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts